Optimise first-line therapy for stable angina, NICE advises
First-line drug therapy should be optimised before patients are offered revascularisation procedures for the management of stable angina, according to a new clinical guideline published by the National Institute for Health and Clinical Excellence. NICE advises that first-line treatment should include one or two antianginal medicines plus a short-acting nitrate and medicines for the secondary prevention of cardiovascular disease. Revascularisation is reserved for patients in whom drug treatment does not control symptoms.
Citation: Clinical Pharmacist URI: 11083348
Recommended from Pharmaceutical Press
Pharmacy Registration Assessment Questions 2 features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own. All questions are in line with current GPhC guidance, enabling you to prepare for the pharmaceutical pre-registration exam with confidence.£35.00Buy now